Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program
Go back to Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program| (NASDAQ: ZNTL) | Delayed: 2.13 -0.11 (4.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.24 | 52 Week High | $ | |||
| Open | $2.25 | 52 Week Low | $ | |||
| Day High | $2.30 | P/E | N/A | |||
| Day Low | $2.10 | EPS | $ | |||
| Volume | 1,101,802 | |||||



